255 related articles for article (PubMed ID: 12490314)
61. Characterization of FRA7B, a human common fragile site mapped at the 7p chromosome terminal region.
Bosco N; Pelliccia F; Rocchi A
Cancer Genet Cytogenet; 2010 Oct; 202(1):47-52. PubMed ID: 20804921
[TBL] [Abstract][Full Text] [Related]
62. Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I.
Ciullo M; Debily MA; Rozier L; Autiero M; Billault A; Mayau V; El Marhomy S; Guardiola J; Bernheim A; Coullin P; Piatier-Tonneau D; Debatisse M
Hum Mol Genet; 2002 Nov; 11(23):2887-94. PubMed ID: 12393800
[TBL] [Abstract][Full Text] [Related]
63. Fragile sites in human and Macaca fascicularis chromosomes are breakpoints in chromosome evolution.
Ruiz-Herrera A; Ponsà M; García F; Egozcue J; García M
Chromosome Res; 2002; 10(1):33-44. PubMed ID: 11863068
[TBL] [Abstract][Full Text] [Related]
64. Cancer chromosome breakpoints and common fragile sites induced by aphidicolin.
Hecht F; Glover TW
Cancer Genet Cytogenet; 1984 Oct; 13(2):185-8. PubMed ID: 6434179
[TBL] [Abstract][Full Text] [Related]
65. Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13.
Ferber MJ; Eilers P; Schuuring E; Fenton JA; Fleuren GJ; Kenter G; Szuhai K; Smith DI; Raap AK; Brink AA
Cancer Genet Cytogenet; 2004 Oct; 154(1):1-9. PubMed ID: 15381365
[TBL] [Abstract][Full Text] [Related]
66. Discovery of over-expressed genes and genetic alterations in breast cancer cells using a combination of suppression subtractive hybridization, multiplex FISH and comparative genomic hybridization.
Xie D; Jauch A; Miller CW; Bartram CR; Koeffler HP
Int J Oncol; 2002 Sep; 21(3):499-507. PubMed ID: 12168092
[TBL] [Abstract][Full Text] [Related]
67. Fragile sites and bladder cancer.
Moriarty HT; Webster LR
Cancer Genet Cytogenet; 2003 Jan; 140(2):89-98. PubMed ID: 12645645
[TBL] [Abstract][Full Text] [Related]
68. The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations.
Krummel KA; Roberts LR; Kawakami M; Glover TW; Smith DI
Genomics; 2000 Oct; 69(1):37-46. PubMed ID: 11013073
[TBL] [Abstract][Full Text] [Related]
69. Molecular basis for expression of common and rare fragile sites.
Zlotorynski E; Rahat A; Skaug J; Ben-Porat N; Ozeri E; Hershberg R; Levi A; Scherer SW; Margalit H; Kerem B
Mol Cell Biol; 2003 Oct; 23(20):7143-51. PubMed ID: 14517285
[TBL] [Abstract][Full Text] [Related]
70. DNA replication stress drives fragile site instability.
Irony-Tur Sinai M; Kerem B
Mutat Res; 2018 Mar; 808():56-61. PubMed ID: 29074228
[TBL] [Abstract][Full Text] [Related]
71. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells.
Ried K; Finnis M; Hobson L; Mangelsdorf M; Dayan S; Nancarrow JK; Woollatt E; Kremmidiotis G; Gardner A; Venter D; Baker E; Richards RI
Hum Mol Genet; 2000 Jul; 9(11):1651-63. PubMed ID: 10861292
[TBL] [Abstract][Full Text] [Related]
72. The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites.
Egeli U; Ozkan L; Tunca B; Kahraman S; Ceçener G; Ergül E; Engin K
Head Neck; 2000 Sep; 22(6):591-8. PubMed ID: 10941161
[TBL] [Abstract][Full Text] [Related]
73. Chromosomal fragile sites and relationship between genetic predisposition to small cell lung cancer.
Karadağ M; Tunca B; Ceçener G; Egeli U; Ozyardimci N; Ege E; Gözü O
Teratog Carcinog Mutagen; 2002; 22(1):31-40. PubMed ID: 11754385
[TBL] [Abstract][Full Text] [Related]
74. Common fragile genes.
Matsuyama A; Croce CM; Huebner K
Eur J Histochem; 2004; 48(1):29-36. PubMed ID: 15145773
[TBL] [Abstract][Full Text] [Related]
75. Correlation of fragile sites and bleomycin induced chromosome break points.
Murthy SK; Patel JK; Krishnamurthy DS
Indian J Exp Biol; 1989 May; 27(5):442-4. PubMed ID: 2480936
[TBL] [Abstract][Full Text] [Related]
76. Molecular cytogenetic analysis of a human breast metastasis model: identification of phenotype-specific chromosomal rearrangements.
Goodison S; Viars C; Urquidi V
Cancer Genet Cytogenet; 2005 Jan; 156(1):37-48. PubMed ID: 15588854
[TBL] [Abstract][Full Text] [Related]
77. Molecular cytogenetic characterization of human breast cancer cell line MDA-MB-468 and its variant 468LN, which displays aggressive lymphatic metastasis.
Xu J; Chambers AF; Tuck AB; Rodenhiser DI
Cancer Genet Cytogenet; 2008 Feb; 181(1):1-7. PubMed ID: 18262045
[TBL] [Abstract][Full Text] [Related]
78. Fragile sites at 16q22 are not at the breakpoint of the chromosomal rearrangement in AMMoL.
Simmers RN; Sutherland GR; West A; Richards RI
Science; 1987 Apr; 236(4797):92-4. PubMed ID: 3470945
[TBL] [Abstract][Full Text] [Related]
79. Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction.
Le Beau MM; Rassool FV; Neilly ME; Espinosa R; Glover TW; Smith DI; McKeithan TW
Hum Mol Genet; 1998 Apr; 7(4):755-61. PubMed ID: 9499431
[TBL] [Abstract][Full Text] [Related]
80. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
